J Med Phys Close
 

Figure 3: Two-dimensional relative dose map (a series) measured using a SLIC-EPID (b series), calculated using a treatment planning system (c series), three dimensional gamma map (d series) and three dimensional signed gamma map for a lung (first row) and breast (second row) cases with 3%/2.54 mm criteria

Figure 3: Two-dimensional relative dose map (a series) measured using a SLIC-EPID (b series), calculated using a treatment planning system (c series), three dimensional gamma map (d series) and three dimensional signed gamma map for a lung (first row) and breast (second row) cases with 3%/2.54 mm criteria